Protease inhibitor (PI) may cause abnormal glucose metabolism, abnormal lipid metabolism,
and metabolic syndrome in HIV-infected adults but less well studied in Asian adolescents …

Our objective was to determine whether HIV-infected children treated with protease
inhibitors (PIs) have different blood lipid, insulin, and glucose levels and body composition …

Objective To evaluate the effects of protease inhibitors (PIs) as antiretroviral therapy in
comparison with other antiretroviral (non-PI) medications on glucose tolerance, lipid …

Background Successful antiretroviral therapy (ART) has dramatically reduced mortality
among HIV-infected children. However, there is growing concern about long-term effects …

Background: HIV protease inhibitors (PIs) are known to disturb lipid metabolism in adults,
leading to hypercholesterolemia. A number of cross-sectional studies have also reported …

Abstract Background Protease inhibitors (PIs) have been associated with metabolic
complications. There is a trend to switch to simpler therapy to improve these disturbances …

OBJECTIVE: To describe nutritional status, body composition and lipid profile in children
and adolescents receiving protease inhibitors. METHODS: Fifty-nine patients, 23 treated …

Objective. To assess the effects of antiretroviral combination therapy that contains protease
inhibitor (PI) on carbohydrate and lipid metabolism in human immunodeficiency virus (HIV) …

Objective: To determine the extent and degree of abnormalities of serum lipids, glucose
homeostasis and abdominal adipose tissue distribution in protease inhibitor (PI)-treated and …

Objectives: To evaluate metabolic abnormalities, beta-cell function, lipid profile and vascular
risk factors in HIV patients on protease inhibitors (PI). Design: Prospective cross-sectional …